Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Investing

Pfizer : PFE

All Pfizer Articles

1508 Articles

Paul Ausick | Jan 26, 2018 at 4:01 PM EST

Intel, Pfizer Drive DJIA Surge Higher on Friday

Intel, Pfizer, 3M, and Disney launched the DJIA to a solid gain Friday.

Chris Lange | Jan 25, 2018 at 10:10 AM EST

Major Pharma Short Interest Keeps Climbing

The January 12 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jan 17, 2018 at 4:15 PM EST

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Apple indicated that it will pay $38 billion in repatriation taxes under the new tax law. Apple says that it…

Chris Lange | Jan 11, 2018 at 9:45 AM EST

Major Pharma Short Interest Takes a Plunge

The December 29 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Jan 8, 2018 at 4:01 PM EST

UnitedHealth, Disney Weigh on DJIA Monday

UnitedHealth, Disney, Pfizer, and General Electric were Monday's laggards among the DJIA stocks.

Chris Lange | Jan 4, 2018 at 9:10 AM EST

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

For the Jones Industrial Average to make its 2018 targets, Pfizer and Merck will to have to do their part…

Chris Lange | Jan 3, 2018 at 10:45 AM EST

Sangamo Jumps on Newest Pfizer Collaboration

Sangamo Therapeutics shares made a handy gain on hump day after the firm announced that it would be collaborating with…

Jon C. Ogg | Jan 3, 2018 at 8:35 AM EST

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

Here is a consensus forecast of each of the 30 Dow Jones Industrial stocks, including a forward 12-month consensus analyst…

Chris Lange | Dec 28, 2017 at 10:25 AM EST

More and More Short Sellers Raising the Stakes in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Dec 26, 2017 at 11:15 AM EST

Meet the Preliminary Dogs of the Dow for 2018

One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the…

Paul Ausick | Dec 20, 2017 at 4:01 PM EST

Disney, General Electric Hobble DJIA on Wednesday

Disney, Pfizer, General Electric, and McDonald's weighed on the DJIA Wednesday.

Jon C. Ogg | Dec 18, 2017 at 12:30 PM EST

Tax Reform Stocking Stuffer: Pfizer Dividend Hike & Much Larger Stock Buyback

Pfizer has just raised its payout by about 6% and more than doubled what it already had on its buyback…

Paul Ausick | Dec 15, 2017 at 4:01 PM EST

Intel, Microsoft Dominate DJIA Friday

Intel, Microsoft, Pfizer, and United Technologies drove the DJIA higher Friday.

Trey Thoelcke | Dec 15, 2017 at 7:20 AM EST

Pfizer Headed for New High After FDA Nod for Joint Disease Treatment

Shares of Pfizer appeared to be headed for a new high after the company announced that the FDA had approved…

Chris Lange | Dec 13, 2017 at 11:05 AM EST

Why Cellectis Is Winning Big With Its Pfizer Partnership

Cellectis saw its shares make a handy gain early on Wednesday after the firm announced preliminary data from its two…

1 … 38 39 40 41 42 … 101

Pfizer : PFE

All Pfizer Articles

Intel, Pfizer Drive DJIA Surge Higher on Friday

Major Pharma Short Interest Keeps Climbing

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Major Pharma Short Interest Takes a Plunge

UnitedHealth, Disney Weigh on DJIA Monday

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

Sangamo Jumps on Newest Pfizer Collaboration

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

More and More Short Sellers Raising the Stakes in Major Pharma

Meet the Preliminary Dogs of the Dow for 2018

Disney, General Electric Hobble DJIA on Wednesday

Tax Reform Stocking Stuffer: Pfizer Dividend Hike & Much Larger Stock Buyback

Intel, Microsoft Dominate DJIA Friday

Pfizer Headed for New High After FDA Nod for Joint Disease Treatment

Why Cellectis Is Winning Big With Its Pfizer Partnership

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

“100 Million Percent Wrong” Suze Orman Rages At Social Security Expert’s “Crazy” Advice

Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up

Rackspace Technology (RXT) Rebounds 22% After Brutal Week

"100 Million Percent Wrong" Suze Orman Rages At Social Security Expert's "Crazy" Advice

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead

“100 Million Percent Wrong” Suze Orman Rages At Social Security Expert’s “Crazy” Advice

Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up

Pfizer : PFE

All Pfizer Articles

Intel, Pfizer Drive DJIA Surge Higher on Friday

Major Pharma Short Interest Keeps Climbing

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Major Pharma Short Interest Takes a Plunge

UnitedHealth, Disney Weigh on DJIA Monday

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

Sangamo Jumps on Newest Pfizer Collaboration

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

More and More Short Sellers Raising the Stakes in Major Pharma

Meet the Preliminary Dogs of the Dow for 2018

Disney, General Electric Hobble DJIA on Wednesday

Tax Reform Stocking Stuffer: Pfizer Dividend Hike & Much Larger Stock Buyback

Intel, Microsoft Dominate DJIA Friday

Pfizer Headed for New High After FDA Nod for Joint Disease Treatment

Why Cellectis Is Winning Big With Its Pfizer Partnership

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

“100 Million Percent Wrong” Suze Orman Rages At Social Security Expert’s “Crazy” Advice

Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up

Rackspace Technology (RXT) Rebounds 22% After Brutal Week

Featured Reads

"100 Million Percent Wrong" Suze Orman Rages At Social Security Expert's "Crazy" Advice

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead